Skip to main content

Table 2 Total amount of CP in urine samples (ng/24 h) from four pharmacists

From: Impact of closed-system drug transfer device on exposure of environment and healthcare provider to cyclophosphamide in Japanese hospital

Pharmacist

Amount of CP prepared (mg/day)

Number of samples

Number of positive samples

Detection rate (%)

CP (ng/24 h)

First test (before PhaSeal®)

1

2900

10

7

70.0

34.9

2

2810

9

6

66.7

27.0

3

3530

8

6

75.0

56.5

4

4860

7

7

100.0

71.3

Mean

3525

8.5

6.5

77.9

47.4

Second test (after PhaSeal®)

1

3000

8

0

0.0

nd

2

4600

7

0

0.0

nd

3

3700

8

1

12.5

6.4

4

4480

8

1

12.5

7.8

Mean

3945

7.8

0.5

6.3

3.6

  1. nd: not detected.
  2. The first test was conducted between August 30 and September 11, 2007.
  3. The second test was conducted between November 7, 2008 and March 17, 2009.
  4. The amount of CP prepared was measured on the day of the urine test.
  5. PhaSeal® was not used for the first test, and was used for the second test.